Good Jennifer L's Form 4 filing
Trevi Therapeutics, Inc. (TRVI) · filed May 14, 2024
- Accession no.
- 0000950170-24-059722
- Filed
- May 14, 2024
- Trade date
- May 10, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $13.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Good Jennifer LCIK 0001229245 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 10, 2024 | Common Stock | MOption exerciseAcquired | +4,578 | $2.19 | +$10,025.82 | 217,891 | Direct | |
| May 10, 2024 | Common Stock | SSaleDisposed | −4,578 | $2.90 | −$13,276.2 | 213,313 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 10, 2024 | Common Stock | MOption exerciseDisposed | −4,578 | $0.00 | $0 | 58,226 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.